Bringing new medications to market quickly and safely is easier through the use of electron microscopy. Co-creation with Hitachi helps Vironova design technology with automated analysis that allows them to make recommendations that help their customers make faster, better decisions to ensure product quality and efficacy.
The Swedish biotechnology company is able to enhance their infrastructure, optimize operations, and streamline and accelerate the development process of new biological drugs for the wider pharmaceutical industry.
Transformation Awards - https://www.hitachinext.com/en-us/transformation-award-2019.html
Vironova Video - https://www.youtube.com/watch?v=Dlzsg9hp_2g #CustomerStories#Blog